(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on today’s article in The New York Times. “Today’s article from The New York Times fundamentally misconstrues the critical value of pharmacy benefit
(Washington, D.C.) — As the debate on prescription drugs continues and policymakers seek solutions to reduce out-of-control prices for Maine consumers, the Pharmaceutical Care Management Association (PCMA) today is announcing the launch of a new, multi-faceted digital public affairs campaign
(Washington, D.C.) — As the debate on prescription drugs continues and policymakers seek solutions to reduce out-of-control prices for Texas consumers, the Pharmaceutical Care Management Association (PCMA) today is announcing the launch of a new, multi-faceted digital public affairs campaign
(Washington, D.C.) —The Pharmaceutical Care Management Association (PCMA) is launching a new print and digital ad campaign – “Protect the Savings” – to defend the savings that pharmacy benefit managers (PBMs) negotiate from drugmakers, and warn against the Administration’s newly
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA), today, is announcing a new ad campaign, “Drug Manufacturers are Pointing Fingers…Again.” With Congress poised to permanently repeal the rebate rule and prevent significant increases in both Medicare beneficiary premiums and Medicare
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today released a new report, “Drug Manufacturer Strategies for Keeping Drug Costs High,” on pharmaceutical industry pricing tactics that increase prescription drug costs for patients. The report, conducted by the research firm Visante,
(Washington, D.C.) — As part of its OnYourRxSide campaign, the Pharmaceutical Care Management Association (PCMA) today released a new video — “What is a PBM?” — detailing the role pharmacy benefit managers (PBMs) play in the prescription drug supply chain
Alex Brill and Angela Banks Dive into the Critical Need for Competition, Big Drug Companies’ Abuse of the Patent System, and Biosimilar Adoption In case you missed it, Angela Banks, Vice President of Policy for the Pharmaceutical Care Management Association
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on passage of prescription drug legislation in New Jersey. “PCMA applauds the New Jersey Assembly for passing S2690 / A3993 / A 2214, legislation that will help ensure New
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott today issued the following statement applauding the Administration’s initiative, announced today, to reduce insulin costs for Medicare enrollees: “We commend the Administration for allowing Part D plan sponsors to
©2024 PCMA. All Rights Reserved.
